Skip to main content

Enhanced anti-platelet therapy is more important than choice of thrombolytic agent in the treatment of myocardial infarction

Publication ,  Journal Article
Krucoff, MW; Green, CL; Trollinger, KM; Maas, A; Moliterno, DJ; Harrington, RA; OConnor, CM; Pope, JE
Published in: CIRCULATION
October 21, 1997

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 21, 1997

Volume

96

Issue

8

Start / End Page

2647 / 2647

Publisher

AMER HEART ASSOC

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Krucoff, M. W., Green, C. L., Trollinger, K. M., Maas, A., Moliterno, D. J., Harrington, R. A., … Pope, J. E. (1997). Enhanced anti-platelet therapy is more important than choice of thrombolytic agent in the treatment of myocardial infarction. CIRCULATION, 96(8), 2647–2647.
Krucoff, M. W., C. L. Green, K. M. Trollinger, A. Maas, D. J. Moliterno, R. A. Harrington, C. M. OConnor, and J. E. Pope. “Enhanced anti-platelet therapy is more important than choice of thrombolytic agent in the treatment of myocardial infarction.” CIRCULATION 96, no. 8 (October 21, 1997): 2647–2647.
Krucoff MW, Green CL, Trollinger KM, Maas A, Moliterno DJ, Harrington RA, et al. Enhanced anti-platelet therapy is more important than choice of thrombolytic agent in the treatment of myocardial infarction. CIRCULATION. 1997 Oct 21;96(8):2647–2647.
Krucoff, M. W., et al. “Enhanced anti-platelet therapy is more important than choice of thrombolytic agent in the treatment of myocardial infarction.” CIRCULATION, vol. 96, no. 8, AMER HEART ASSOC, Oct. 1997, pp. 2647–2647.
Krucoff MW, Green CL, Trollinger KM, Maas A, Moliterno DJ, Harrington RA, OConnor CM, Pope JE. Enhanced anti-platelet therapy is more important than choice of thrombolytic agent in the treatment of myocardial infarction. CIRCULATION. AMER HEART ASSOC; 1997 Oct 21;96(8):2647–2647.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 21, 1997

Volume

96

Issue

8

Start / End Page

2647 / 2647

Publisher

AMER HEART ASSOC

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology